knowledge -WSS

knowledge

author：comprehensive 2025-09-10 08:41:23 - browse：3

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Why psychiatrists like me stop taking insurance

explore

WSS

New weight loss drugs work. But how can they best be used?

The debate over Covid

The FDA must approve intranasal treatments for anaphylaxis

Companies helping big Covid

Feng Zhang CRISPR delivery startup lays off quarter of staff

3 medical device trends to watch in 2024

focus

knowledge

leisure time

At least 13 dead in Texas as scorching temps continue

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

At least 13 dead in Texas as scorching temps continue

Feng Zhang, Grail founder join forces on new gene editing startup

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

At least 13 dead in Texas as scorching temps continue

Ahead of JPM, here's who's profiting most in health care

Medical records are filled with copy

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

entertainment

Feng Zhang CRISPR delivery startup lays off quarter of staff

The biotech scorecard for Q1: 17 stock

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

3 medical device trends to watch in 2024

Watch the official trailer for 'Ahsoka' series

leisure time

explore

explore

focus